Matthew J. Ellis, MD, on Endocrine Therapy–Resistant Breast Cancer
2014 San Antonio Breast Cancer SymposiumMatthew J. Ellis, MD, PhD, of the Baylor College of Medicine, offers a brief synopsis of his plenary lecture, "Genome-Directed Therapeutics for Endocrine Therapy–Resistant Estrogen Receptor–Positive Breast Cancer."
Related Videos
Charles E. Geyer, Jr, MD, FACP, on the SOFT Trial
Charles E. Geyer, Jr, MD, FACP, of Massey Cancer Center, discusses abstract S3-08,
Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08,
Lee S. Schwartzberg, MD, FACP of The West Clinic and Ian E. Krop, MD, PhD, of the Dana-Farber Cancer Institute discuss the FERGI trial and data from phase I and ph...
Clifford A. Hudis, MD, FACP, on the SOFT Trial
Lee S. Schwartzberg, MD, FACP, and Ian E. Krop, MD, PhD, on PI3K and PD-L1 Inhibition Data
Lisa A. Carey, MD, on Pembrolizumab in Advanced Triple-Negative Breast Cancer
Lisa A. Carey, MD, of UNC Lineberger Comprehensive Cancer Center, offers her thoughts on abstract S1-09,
Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS, discuss the role of ovarian suppression and hormonal therapy in premenopausal women.
Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS, Discuss the SOFT Trial
